Literature DB >> 17510706

Mature B cells class switched to IgD are autoreactive in healthy individuals.

Kristi Koelsch1, Nai-Ying Zheng, Qingzhao Zhang, Andrew Duty, Christina Helms, Melissa D Mathias, Mathew Jared, Kenneth Smith, J Donald Capra, Patrick C Wilson.   

Abstract

Determination of the origin and fate of autoreactive B cells is critical to understanding and treating autoimmune diseases. We report that, despite being derived from healthy people, antibodies from B cells that have class switched to IgD via genetic recombination (and thus become class switched to C delta [C delta-CS] cells) are highly reactive to self antigens. Over half of the antibodies from C delta-CS B cells bind autoantigens on human epithelioma cell line 2 (HEp-2) cells or antinuclear antigens, and a quarter bind double-stranded DNA; both groups of antibodies are frequently polyreactive. Intriguingly, some C delta-CS B cells have accumulated basic residues in the antibody variable regions that mediate anti-DNA reactivity via somatic hypermutation and selection, while other C delta-CS B cells are naturally autoreactive. Though the total percentage was appreciably less than for C delta-CS cells, a surprising 31% of IgG memory cell antibodies were somewhat autoreactive, and as expected, about 24% of naive cell antibodies were autoreactive. We interpret these findings to indicate either that autoreactive B cells can be induced to class switch to IgD or that autoreactive B cells that use IgD as the B cell receptor are not effectively deleted. Determination of the mechanism by which the majority of C delta-CS B cells are autoreactive may be important in understanding peripheral tolerance mechanisms and may provide insight into the enigmatic function of the IgD antibody.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17510706      PMCID: PMC1866247          DOI: 10.1172/JCI27628

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  33 in total

1.  Predominant autoantibody production by early human B cell precursors.

Authors:  Hedda Wardemann; Sergey Yurasov; Anne Schaefer; James W Young; Eric Meffre; Michel C Nussenzweig
Journal:  Science       Date:  2003-08-14       Impact factor: 47.728

2.  Intricacies of anti-DNA autoantibodies.

Authors:  Marko Z Radic; Martin Weigert
Journal:  J Immunol       Date:  2004-03-15       Impact factor: 5.422

Review 3.  Cellular mechanisms of immunologic tolerance.

Authors:  G J Nossal
Journal:  Annu Rev Immunol       Date:  1983       Impact factor: 28.527

4.  Circulating human B cells that express surrogate light chains and edited receptors.

Authors:  E Meffre; E Davis; C Schiff; C Cunningham-Rundles; L B Ivashkiv; L M Staudt; J W Young; M C Nussenzweig
Journal:  Nat Immunol       Date:  2000-09       Impact factor: 25.606

5.  Autoreactivity in human IgG+ memory B cells.

Authors:  Thomas Tiller; Makoto Tsuiji; Sergey Yurasov; Klara Velinzon; Michel C Nussenzweig; Hedda Wardemann
Journal:  Immunity       Date:  2007-02       Impact factor: 31.745

Review 6.  Structural and functional properties of membrane and secreted IgD.

Authors:  J L Preud'homme; I Petit; A Barra; F Morel; J C Lecron; E Lelièvre
Journal:  Mol Immunol       Date:  2000-10       Impact factor: 4.407

7.  Human immunoglobulin selection associated with class switch and possible tolerogenic origins for C delta class-switched B cells.

Authors:  Nai-Ying Zheng; Kenneth Wilson; Xiaojian Wang; Angela Boston; Grant Kolar; Stephen M Jackson; Yong-Jun Liu; Virginia Pascual; J Donald Capra; Patrick C Wilson
Journal:  J Clin Invest       Date:  2004-04       Impact factor: 14.808

8.  Antibodies to polynucleotides: distribution in human serums.

Authors:  D Koffler; R I Carr; V Agnello; T Fiezi; H G Kunkel
Journal:  Science       Date:  1969-12-26       Impact factor: 47.728

9.  Biased Iglambda expression in hypermutated IgD multiple myelomas does not result from receptor revision.

Authors:  M van der Burg; R J Bende; W M Aarts; A W Langerak; J J M van Dongen; C J M van Noesel
Journal:  Leukemia       Date:  2002-07       Impact factor: 11.528

10.  Receptor revision of immunoglobulin heavy chain variable region genes in normal human B lymphocytes.

Authors:  P C Wilson; K Wilson; Y J Liu; J Banchereau; V Pascual; J D Capra
Journal:  J Exp Med       Date:  2000-06-05       Impact factor: 14.307

View more
  63 in total

Review 1.  Polyreactive antibodies in adaptive immune responses to viruses.

Authors:  Hugo Mouquet; Michel C Nussenzweig
Journal:  Cell Mol Life Sci       Date:  2011-11-02       Impact factor: 9.261

2.  Peripheral B cell tolerance and function in transgenic mice expressing an IgD superantigen.

Authors:  Bao Hoa Duong; Takayuki Ota; Djemel Aït-Azzouzene; Miyo Aoki-Ota; José Luis Vela; Christoph Huber; Kevin Walsh; Amanda L Gavin; David Nemazee
Journal:  J Immunol       Date:  2010-03-15       Impact factor: 5.422

Review 3.  New insights into the enigma of immunoglobulin D.

Authors:  Kang Chen; Andrea Cerutti
Journal:  Immunol Rev       Date:  2010-09       Impact factor: 12.988

4.  The truth on IgD in the ploy of immune surveillance and inflammation.

Authors:  Donato Rigante
Journal:  Immunol Res       Date:  2016-04       Impact factor: 2.829

Review 5.  The enigmatic function of IgD: some answers at last.

Authors:  Cindy Gutzeit; Kang Chen; Andrea Cerutti
Journal:  Eur J Immunol       Date:  2018-06-12       Impact factor: 5.532

6.  Key developmental transitions in human germinal center B cells are revealed by differential CD45RB expression.

Authors:  Stephen M Jackson; Natessa Harp; Darshna Patel; Jordan Wulf; Erich D Spaeth; Uzoamaka K Dike; Judith A James; J Donald Capra
Journal:  Blood       Date:  2008-12-04       Impact factor: 22.113

Review 7.  Immunological tolerance as a barrier to protective HIV humoral immunity.

Authors:  Kristin Ms Schroeder; Amanda Agazio; Raul M Torres
Journal:  Curr Opin Immunol       Date:  2017-07-17       Impact factor: 7.486

8.  Immunoglobulin D enhances immune surveillance by activating antimicrobial, proinflammatory and B cell-stimulating programs in basophils.

Authors:  Kang Chen; Weifeng Xu; Melanie Wilson; Bing He; Norman W Miller; Eva Bengtén; Eva-Stina Edholm; Paul A Santini; Poonam Rath; April Chiu; Marco Cattalini; Jiri Litzman; James B Bussel; Bihui Huang; Antonella Meini; Kristian Riesbeck; Charlotte Cunningham-Rundles; Alessandro Plebani; Andrea Cerutti
Journal:  Nat Immunol       Date:  2009-06-28       Impact factor: 25.606

9.  Regulatory T cells and their role in rheumatic diseases: a potential target for novel therapeutic development.

Authors:  Diana Milojevic; Khoa D Nguyen; Diane Wara; Elizabeth D Mellins
Journal:  Pediatr Rheumatol Online J       Date:  2008-12-01       Impact factor: 3.054

10.  Short- and long-term effects of anti-CD20 treatment on B cell ontogeny in bone marrow of patients with rheumatoid arthritis.

Authors:  Maria Rehnberg; Sylvie Amu; Andrej Tarkowski; Maria I Bokarewa; Mikael Brisslert
Journal:  Arthritis Res Ther       Date:  2009-08-17       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.